D‐dopachrome tautomerase is over‐expressed in pancreatic ductal adenocarcinoma and acts cooperatively with macrophage migration inhibitory factor to promote cancer growth. Issue 9 (28th July 2016)

• Record Type: Journal Article
• Authors: Guo, Dawei; Guo, Jinshuai; Yao, Junchao; Jiang, Kun; Hu, Jianhua; Wang, Bo; Liu, Haiyang; Lin, Lin; Sun, Wenyu; Jiang, Xiaofeng
• Is Part Of: International journal of cancer. Volume 139:Issue 9(2016:Nov. 01)
• Page Start: 2056
• Page End: 2067
• Publication Date: 2016-07-28
• Subjects: D‐dopachrome tautomerase -- macrophage migration inhibitory factor -- pancreatic cancer -- proliferation -- tumor growth -- invasion; Cancer -- Periodicals; Cancer -- Prevention -- Periodicals; 616.994
• DOI: 10.1002/ijc.30278
• Languages: English
• ISSNs: 0020-7136

Abstract

Abstract : Previous studies have established the important role of MIF in the development of pancreatic ductal adenocarcinoma (PDAC) for both therapeutic and diagnostic perspectives, but little is known about the expression and function of D‐dopachrome tautomerase (DDT), a functional homolog of MIF, in PDAC. In the present study, we demonstrated that DDT was over‐expressed in PDAC tissues in a pattern correlated with MIF. In the pancreatic cancer cell lines, PANC‐1, BXPC‐3 and ASPC‐1, both DDT and MIF were expressed and co‐localized with each other in the endosomal compartments and plasma membrane. Knockdown of DDT and MIF in PANC‐1 cells cooperatively inhibited ERK1/2 and AKT phosphorylation, increased p53 expression, and reduced cell proliferation, invasion and tumor formation. These effects were rescued by the re‐expression of MIF or DDT, but not by the forced expression of the tautomerase‐deficient mutants of DDT and MIF, P1G‐DDT and P1G‐MIF. Finally, we observed that 4‐iodo‐6‐phenylpyrimidine (4‐IPP), a covalent tautomerase inhibitor of both DDT and MIF, attenuated PANC‐1 cell proliferation and colony formation in vitro and tumor growth in vivo . Thus, targeting the tautomerase sites of both MIF and DDT may offer more efficient therapeutic benefits to PDAC patients. Abstract : What's new? The cytokine MIF, released by macrophages, helps pancreatic cancer gain a foothold, and therapies that inhibit MIF are already in use. Less is known about DDT, a homolog of MIF that activates the same pro‐inflammatory pathways that MIF does. These authors investigated whether DDT might give MIF a boost. First, they showed that pancreatic cancer cells do overexpress DDT. Removing DDT and MIF from pancreatic cancer cells slowed cell proliferation and tumor formation. Finally, they slowed tumor growth in mice using a tautomerase inhibitor of DDT and MIF. The two enzymes, it seems, work together to spur cancer growth, and this tautomerase inhibitor could lead to new therapeutic strategies.